Multiple Myeloma: A Modern Look at an Ancient Disease and 2025’s Therapeutic Breakthroughs
Discover the latest advancements in multiple myeloma treatment, including new therapies and FDA approvals that enhance patient outcomes and survival…
Examining the One Big Beautiful Bill Act on Prescription Drugs: Benefits and Criticisms
The bill promises lower drug costs and greater innovation, but critics still have concerns.
Will the “Big, Beautiful Bill” Accelerate the Direct Buy and Direct Pay Marketplace?
Another bill, another day for the erosion of pharmacy benefits as a means of affording a prescription.
PHESGO Implementation Cuts Chair Time and Boosts Efficiency in HER2-Positive Breast Cancer Care
PHESGO reduced patient infusion time from 90 minutes to as little as 5, enhancing patient experience while maintaining efficacy and…
Donanemab-Azbt Demonstrated Long-Term Efficacy in Slowing Cognitive Decline
Donanemab-azbt shows sustained benefits in slowing cognitive decline in Alzheimer disease, emphasizing the value of early intervention and treatment.
Trastuzumab Biosimilar Demonstrates Sufficient Efficacy in HER2+ Advanced Gastric Cancer
Herzuma shows promising efficacy and safety as a cost-effective biosimilar for treating HER2+ advanced gastric cancer, offering new hope for…
